Microbiology

Pseudolysogeny is a latent state in which phage development is delayed after infection and has been proposed to promote phage persistence under unfavorable conditions. Virulent phage T3 has been reported to establish pseudolysogeny after infecting starved E. coli, then resume lytic replication following transfer to nutrient-rich media, a phenotype linked to the T3 SAMase gene. Here, we revisited the findings of Krueger et al. (1975) to test pseudolysogeny in T3 and examine phage propagation under nutrient-limited conditions. Both T3 and T7 showed impaired propagation under nutrient limitation, with the most stringent conditions causing substantial losses in recoverable infective centers. T3 was modestly more resilient than T7 under these conditions, but we were unable to reproduce the reported phenotype in which T3 remained latent while T7 replicated normally. Supplementation of minimal medium with small amounts of LB supported propagation of both phages, and a repeat experiment designed to more closely match the historical protocol, including post-adsorption reduction of extracellular phage carryover, likewise failed to reveal a T3-specific pseudolysogenic state. Together, our results indicate that, in this experimental system, phage propagation dynamics are more consistently explained by nutrient conditions and media switching than by starvation prior to infection. These findings suggest that the previously reported T3 pseudolysogeny phenotype may depend on additional environmental or methodological factors and underscore the importance of revisiting historically reported phage behaviors using modern controls.

Bacteriophage cocktails are widely assumed to improve treatment of multidrug-resistant Klebsiella pneumoniae, yet many therapeutic phages target capsular polysaccharides (CPS), potentially promoting antagonism and shared resistance. Here, we investigated how receptor usage, resistance evolution, and dosing order influence the activity of two K1-specific phages, Loop and Spear, against a hypervirulent ST23 strain. Using in vitro killing assays and Bliss analysis, we show that a 1:1 Loop and Spear cocktail did not improve bacterial suppression compared to Loop alone and instead exhibits multiplicity-of-infection-dependent antagonism, consistent with competition for a shared CPS receptor. Sequential dosing revealed strong order dependence: treatment with Spear followed by Loop qualitatively altered growth trajectories in a subset of cultures, whereas the reverse order or repeated dosing, provided little additional benefit. Resistance profiling showed that mutants resistant to both phages predominantly carried mutations in capsule synthesis or export genes, whereas Spear specific resistance was associated with mutations in fkpA, encoding a periplasmic chaperone for outer membrane protein biogenesis. Adsorption assays confirmed that capsule associated mutations abolished Loop attachment, while {Delta}fkpA mutants retained Loop binding, supporting CPS to be a primary receptor with Spear additionally requiring an FkpA-dependent secondary receptor. In a Galleria mellonella infection model, a capsule-mutant resistant isolate showed reduced virulence, and only sequential therapy with Spear followed by Loop improved survival beyond monotherapy. These findings show that receptor sharing can render phage cocktails antagonistic and highlight sequential, order-aware regimens as a strategy to exploit resistance-virulence trade-offs while limiting the emergence of double-resistant mutants.

The toxicity of the amino acids glycine and L-serine at high concentrations in bacteria was discovered decades ago. In this work, we used deep transposon insertion sequencing (Tn-seq) experiments to determine the genes necessary to tolerate excess L-serine, diglycine or glycine in the human pathogen Staphylococcus aureus. Our results indicate that intracellular accumulation of specific counterbalancing amino acids--such as alanine in excess glycine--is the primary mechanism of resistance to amino acid toxicity. Consistent with this model, specific amino acid and peptide uptake transporters were required for fitness in each treatment; the peptide transporter DtpT was crucial for fitness in excess L-serine or glycine, and the alanine transporter AapA was essential in diglycine. Tn-seq results also identified the cystine/cysteine uptake transporter TcyABC as necessary in excess L-serine, suggesting that both peptide and cysteine uptake contribute to L-serine tolerance. In addition to uptake mechanisms, glycine and diglycine toxicity is neutralized by D-alanine aminotransferase (Dat), which is required for D-alanine synthesis. The requirement for Dat and DtpT function--but not AapA--in excess glycine is explained by excess glycine inhibiting alanine uptake. Building on this finding, we found that combined treatment with glycine and the alanine analog antibiotic D-cycloserine was strongly synergistic in inhibiting S. aureus growth. Overall, our findings identify targetable mechanisms underlying excess amino acid tolerance in S. aureus, with implications for developing novel combination treatments using the accessible and biocompatible amino acids glycine and L-serine. IMPORTANCEGrowing evidence supports the beneficial effects of glycine and L-serine supplementation in combating bacterial infections. Previous researchers have found that combining antibiotic treatment with high glycine concentrations has additive effects with many antibiotics, even reversing resistance to antibiotics in some bacteria. In vivo, activating glycine and L-serine metabolism heightens the sensitivity of bacterial pathogens to the host complement system, and studies of glycine or L-serine treatments show low toxicity and reduced inflammation in mouse and human subjects. This study reveals that glycine may be an effective antibiotic adjuvant with D-cycloserine, and treatment with glycine or L-serine could potentiate other drugs that target alanine or cysteine metabolism, respectively.

Salmonellosis continues to be one of the most important causes of food-borne illness in the U.S. An additional concern with this bacterial pathogen is that infections with multiple-antibiotic-resistant Salmonella strains are becoming untreatable infectious diseases. Poultry meat and eggs are major sources of Salmonella food-borne illness, due to carriage of these bacterial pathogens in the intestinal microbiome of chickens. A food safety priority, as stated by the USDA, is a significant reduction in carriage of pathogenic Salmonella species in poultry which would significantly improve food safety and reduce cases of human salmonellosis contracted from consumption of contaminated poultry. While this goal has been a priority for many years, basic research and animal management efforts have not achieved significant control of Salmonella carriage. This study represents an alternative approach to reduce or eliminate carriage of Salmonella in poultry flocks. We characterized a type 1 fimbrial allele of Salmonella that confers high levels of adherence to various host cells. We then engineered an E. coli Nissle 1917 probiotic strain that expresses this Salmonella adherence factor at high levels. The E. coli Nissle 1917 is used as the scaffold strain for this work since this E. coli strain has received the FDA designation of Generally Regarded As Safe (GRAS) and has been used for many years as a probiotic to treat human intestinal disorders. Our E. coli Nissle strain was engineered to use an in vivo selection system for a plasmid carrying the cloned Salmonella type 1 fimbrial genes, so that the strain can be used as a probiotic without any antibiotic resistance-encoding genes requiring antibiotic selection for maintenance of the desired phenotype. Our probiotic strain displays high levels of adherence to host cells, in fact higher levels of adherence than a Salmonella strain carrying the same type 1 fimbrial genes. We demonstrate that the probiotic strain significantly outcompetes pathogenic Salmonella strains for adherence to tissue culture cells and in vivo experimental challenges revealed that the probiotic strain mediates a significant exclusion of Salmonella from the intestines of broilers, layers, and turkeys.

Antibiotic resistance is a growing global health crisis, yet resistance is almost exclusively quantified under aerobic laboratory conditions that fail to reflect the complex microenvironments bacteria encounter during infection. Many clinically important infection sites, such as airways of individuals with cystic fibrosis or chronic wounds, are microaerobic to anoxic. To address this, we investigated how anoxia alters antibiotic resistance determinants, hypothesizing that anaerobic metabolism might change the fitness effects and selection of resistance mutations. We used experimental evolution to propagate Pseudomonas aeruginosa populations for approximately 200 generations under conditions differing in oxygen availability (oxic vs. anoxic), growth mode (biofilm vs. planktonic), and tobramycin (TOB) exposure (subinhibitory increasing to inhibitory concentrations). Subinhibitory exposure was sufficient to achieve resistance 2-4x greater than ancestral levels, with anoxic populations consistently showing higher minimum inhibitory concentrations than oxic comparisons. Resistance developed through condition-dependent genomic targets: mutations in amgS were selected in oxic populations, while fusA1 and ptsP mutations arose across all conditions. Notably, mexT mutations were nearly universally selected, particularly under anoxic or tobramycin-exposed conditions. mexT inactivation may also enhance virulence through altered quorum sensing and increased rhamnolipid production. Anoxic populations additionally exhibited significantly increased biofilm formation, some exceeding 1000% of ancestral levels, reduced twitching motility driven by type IV pilus gene mutations, and greater competitive fitness. Together, these findings demonstrate that oxygen availability shapes resistance evolution in P. aeruginosa, with the anoxic environment selecting for a more virulent, sessile, and antibiotic-resistant phenotype.

Murepavadin is a Pseudomonas-specific antibiotic that targets LPS transport protein LptD. However, whilst the mode of action of murepavadin is well defined, the mechanism by which the drug gains access to LptD remains unresolved. Here, we demonstrate a self-directed uptake mechanism for murepavadin, whereby binding to lipid A induces outer membrane disruption, enabling entry of the antibiotic into the periplasm and access to LptD. Murepavadin-LPS interactions were not specific to P. aeruginosa, however, and were found to cause OM disruption across a wide range of Gram-negative bacteria, resulting in increased antibiotic susceptibility. We also discovered that murepavadin-mediated OM disruption sensitised E. coli to the membrane attack complex of the complement system. In conclusion, murepavadin is a broad-spectrum membrane permeabiliser, which results in increased bacterial susceptibility to antibiotics and host defences.

Lipopolysaccharide (LPS) is a major component of the outer membrane of Gram-negative bacteria, contributing to membrane integrity and environmental interactions. Genome-wide studies defining bacterial gene functions have been extensively performed in the model strain Escherichia coli K-12 which lacks O-antigen (OAg), and therefore does not produce smooth LPS (S-LPS). Consequently, the genetic requirements for S-LPS production in this model system remain incompletely defined. Here, a functional wbbL gene was introduced into the E. coli K-12 KEIO single-gene deletion mutant library to restore OAg synthesis, enabling genome-wide analysis of S-LPS production by screening with colicin E2 (ColE2) and validated with LPS silver staining. This identified 319 mutants with increased sensitivity to ColE2 in the presence of OAg, suggesting broader envelope-associated effects during screening. In addition, 27 mutants showed defects in S-LPS production, corresponding to genes involved in OAg biosynthesis, LPS core and sugar precursor synthesis, OAg ligation and regulation, and enterobacterial common antigen biosynthesis. A further 18 mutants initially appeared defective in S-LPS production but could not be validated upon reconstruction, and whole-genome sequencing revealed secondary mutations responsible for the observed phenotypes. This study provides a validated genetic framework for S-LPS production in E. coli K-12 and highlights the importance of rigorous validation in genome-wide screening approaches.

The RND efflux pump FemT encoded by SAUSA300_2213 of Staphylococcus aureus USA300 is co-transcribed with femX which has an essential role in synthesizing the Lipid II precursor of peptidoglycan. Anticipating that this arrangement reflects a critical accessory role for femT, we constructed USA300{Delta}femT to assess its function. Although growth of USA300{Delta}femT in tryptic soy broth (TSB) was not impaired, transcriptomic data revealed a mild cellular stress response, accompanied by reduced expression of ohyA and crt genes involved in fatty acid metabolism and carotenoid lipid synthesis respectively. Accordingly, USA300{Delta}femT exhibited impaired growth on exposure to saturated and unsaturated fatty acids, and exposure to subinhibitory 50 {micro}M palmitic acid promoted accumulation of reactive oxygen species, reduced respiratory activity, and altered membrane function and morphology. The transcriptome of cells grown under this condition revealed strongly attenuated expression of ohyA and crt, and several genes required for oxidative and anaerobic respiration, concomitant with strongly enhanced expression of several stress response pathways. Cellular metabolites were also profoundly altered. Finally, lipidomic analysis of USA300{Delta}femT exposed to oleic acid revealed increased incorporation of oleic acid into phosphatidylglycerol, accompanied by a significant reduction in undecaprenol C55 lipid carrier, and respiratory quinones MK-7 and MK-8. Our data are consistent with a role for FemT in maintaining cellular lipid homeostasis by promoting efflux of isoprenoid and carotenoid lipids that are prone to oxidative damage, including C55 and menaquinones that undergo cyclic reactions in peptidoglycan synthesis and electron transport. IMPORTANCEThe FemT efflux pump of S. aureus is co-expressed in an operon with femX encoding an essential enzyme needed to complete the synthesis of peptidoglycan precursor Lipid II. Although this alluded to a specific role for FemT in supporting peptidoglycan synthesis, our data are instead consistent with a general role in efflux of cellular isoprenoids and carotenoid lipids that are susceptible to oxidation during routine cellular functions. Consequently, S. aureus became strongly dependent on FemT function when exogenous host-derived fatty acids were being actively metabolized. This represents a significant advance in our understanding of the role of an RND efflux pump in supporting routine growth-related functions of S. aureus and exposes a function that could be targeted to impair S. aureus growth on exposure to host-derived fatty acids.

Bacteria often evolve resistance to phage infection by altering the cell-surface structures required for viral adsorption. However, the role extracellular metabolites play in influencing phage susceptibility and the evolution of phage resistance remains unclear. Here, we evaluated whether sustained exposure to putrescine, a polyamine released during phage-mediated cell lysis, alters susceptibility of the pathogen Pseudomonas aeruginosa to the type IV pili-dependent phage DMS3vir. Using adaptive laboratory evolution over [~]66 generations, we evolved P. aeruginosa with or without putrescine and with or without DMS3vir. As expected, direct phage exposure rapidly led to complete phage resistance. Interestingly, populations exposed to putrescine also developed phage resistance by the end of the experiment, despite having never encountered the phage. Whole-population genome sequencing revealed parallel mutations in genes associated with type IV pili and the global transcriptional regulator mexT. Using transposon insertion mutants in the type IV ATPases pilT and pilB, we confirmed that disruption of these genes leads to DMS3vir phage resistance. We also used a type IV pilus biogenesis factor fimV transposon mutant, which showed a putrescine-dependent reduction in phage susceptibility. These findings show that sustained exposure to a host-derived metabolite can drive the evolution of phage resistance through modification of key phage-adsorption sites and regulatory genes. Our work identifies elevated polyamine exposure as a selective pressure that promotes type IV pili-mediated phage resistance, even in the absence of phage exposure. IMPORTANCEPseudomonas aeruginosa is a major cause of hospital-acquired infections and a key priority for phage-based therapies. Previous work has shown that the polyamine putrescine is released into the extracellular environment during cell lysis. These signals can then transiently reduce susceptibility to bacteriophage infection and alert neighboring cells to danger. Our research demonstrates that long-term exposure to putrescine can drive heritable phage resistance without prior exposure to phage. We show that resistance is linked to mutations in genes involved in type IV pili assembly. This work further demonstrates the critical role that polyamines can play in promoting phage resistance in bacterial communities.

People with intellectual disabilities and their communities are rarely involved in setting priorities for research. Our study addressed this gap through consultations with the UK communities of three genetic syndromes in which intellectual disabilities are common: Down syndrome (DS), Fragile X syndrome (FXS) and Williams syndrome (WS). The study aimed to provide an understanding of (1) the views of the DS, FXS and WS communities on current UK research; (2) their priorities for future research; and (3) participants views of engaging with UK research. We conducted focus group discussions with 39 community members including: children and adults with DS, FXS and WS; parent/carers of people with DS, FXS and WS; practitioners and researchers who work with these communities. Our study was carried out in collaboration with a Steering Group and two Advisory Groups of DS, FXS and WS community members. We identified three themes. First, participants shared their dissatisfaction with the current research landscape and wanted a more balanced landscape, with more research with direct application to the daily lives of people with DS, FXS and WS. Second, community members emphasised the importance of translating research into practice, advocating for better access to research and more meaningful participation to research of individuals with lived experience. Third, our study not only identified what should be the focus of future research on DS, FXS and WS, but also how researchers should conduct their research. Whilst including children in our sample was a strength, there were some limitations to the diversity of our sample; children with FXS were not represented and gender, ethnic and geographic diversity could have been broader. Nevertheless, we hope that our findings will change the future of research in this field so that research carried out in the name of individuals with intellectual disabilities such as DS, FXS and WS, is of direct use to these communities.

A paradigm shift is underway in microbiology: many prokaryotes, long considered to lack the compartmentalization present in all eukaryotic life, have been found to possess a great diversity of protein based intracellular compartments. Notably, the genomes of many marine and freshwater anaerobic ammonium oxidizing (anammox) bacteria encode one of these compartmentalization strategies; encapsulin nanocompartments. These systems structure suggests a role for anammox encapsulins in the anammox metabolism, a process of global biogeochemical significance, which results in the loss of biologically available nitrogen from aquatic environments. Here we test if the most common anammox encapsulin architecture could provide a mechanism to detoxify NO, one of the reactive intermediates produced in the core anammox metabolism. Through experiments in which the Kuenenia stuttgartiensis encapsulin was heterologously expressed by an inducible plasmid in E. coli, we show evidence that suggests the K. stuttgartiensis encapsulin provides no protection from NO.

Aminopeptidases are widely distributed in bacteria, but outside of a few model strains, their function is largely unexplored. Focussing on beta-alanine aminopeptidase activity, a new series of selectively-activatable, caged fluorescent probes were designed and synthesised. A beta alanine amino acid was coupled to resorufin or 7-hydroxycoumarin via a self-imolative linker, such that amino acid removal led to gain of fluorescence. These were used to probe selectivity and specificity of probe activation, against a range of priority drug-resistant pathogens. When added to bacterial growth curves run in Muller Hinton broth, these probes allowed essentially real time fluorescence measurement of activation by bacterial species, modelled on the standard microbroth dilution method. Activation was observed for all Pseudomonas aeruginosa and Burkholderia spp strains tested. Selective activation was seen for Ochrabactrum species, with the probe activated by O.anthropii (2/4 strains) but not O.intermedium and strain-specific activation was seen for some isolates of Serratia marcescens (2/4 strains). No activation was observed in any isolates of Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii or Staphylococcus aureus or Eneterocccus faecium/faecalis PAO1 transposon mutants in the putative beta-alanine aminopeptidase gene (annotated as bapF or dmpA; PW3678) showed no activation of the probe in growth assays, confirming the specificity of the probe for beta-alanine aminopeptidase. Transposon mutants in other aminopeptidase genes, including those encoded by pepN, PepP and the prolyl aminopeptidase gene had no effect on probe activation in PAO1. Based on the operon structure in PA01, transposon mutants in two adjacent genes were also tested for probe activation. Mutants in both a putative transcriptional regulator (PW3674) and a predicted amino acid permease (PW3676) retained their ability to activate the beta-alanine probes with activation significantly higher than the wild type, when assessed by the total fluorescence yield after 10 hours growth. This points to both redundancy in permease function and perhaps the presence of a feedback regulatory mechanism controlling beta alanine aminopeptidase activity in P.aeruginosa. Given that the operon structure is conserved in other species, this may point to a common mechanism of beta alanine aminopeptidase function, perhaps related to exploiting beta-alanine containing peptides in certain environmental niches.

The use of antimicrobial compounds in humans, animals and in agriculture leads to environmental antimicrobial contamination through domestic, industrial and agricultural wastewater. Efforts have been made to perform environmental risk assessments based on the potential of these compounds to select for antimicrobial resistance (AMR) at certain concentrations in bacteria. This has resulted in predicted no effect concentrations (PNEC) which determine the minimum thresholds required to select for resistance. However, the effects of these compounds on intracellular transposition within bacterial isolates, a major driver of AMR, have not been previously assessed. Here, we assess the effect of differing sub-inhibitory concentrations of the third-generation cephalosporin, ceftriaxone, on the rate of intracellular transposition in combination with colistin and kanamycin. Two triple replicons systems (RS1 and RS2) were developed to assess this, each containing a chromosome, plasmid and entrapment vector. We show that sub-inhibitory concentrations of ceftriaxone exert hormetic effects on the intracellular transposition rate in RS1 and a steady linear increase in RS2. This defines a predicted no effect concentration for transposition (PNECT) for ceftriaxone as 320 ng/L in RS1 and 3200 ng/L in RS2. This provides a minimum threshold for the environmental impact of ceftriaxone on biological systems at the sub-cellular scale, which is applicable to industrial standards of waste management, where consideration of ecological impact is central.

Iron is an essential micronutrient that shapes host-pathogen interactions during infection. However, the contribution of iron to the virulence adaptation of the Enterobacter cloacae complex (ECC) remain poorly characterized. This study profiled the effects of iron on E. roggenkampii and E. asburiae clinical isolates. Growth kinetics were assessed in Luria-Bertani broth supplemented with varying iron concentrations and 5% sheep blood, and EDTA. Recovered strains were used for motility and antibiotic susceptibility assays. Phenotypic virulence trait of iron-naive and iron-recovered strains was determined using biofilm formation assays. Whole-genome sequencing was conducted to identify genetic determinants associated with iron acquisition and metabolism. Presence of iron increased bacterial growth, reduced antibiotic susceptibility, and enhanced biofilm formation. At higher iron concentrations, iron-recovered strains exhibited increased biofilm biomass, while there was a high biofilm formation with iron-naive strains at lower iron levels. Genomic analysis identified genes associated with ferrous and ferric iron transport, heme uptake, siderophore biosynthesis, and virulence-related functions, including adhesion and biofilm formation. These findings demonstrate that iron availability and prior exposure modulate ECC physiology and phenotypic traits associated with virulence, supporting a role for iron in shaping adaptive pathogenic potential. Graphical AbstractThe influence of iron metabolism on virulence adaptation of Enterobacter cloacae complex O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=107 SRC="FIGDIR/small/737523v1_ufig1.gif" ALT="Figure 1"> View larger version (28K): org.highwire.dtl.DTLVardef@aa351eorg.highwire.dtl.DTLVardef@855345org.highwire.dtl.DTLVardef@11e0da5org.highwire.dtl.DTLVardef@11f851_HPS_FORMAT_FIGEXP M_FIG C_FIG

Pseudomonas aeruginosa is an opportunistic pathogen that often adopts persistent phenotypes -- such as biofilm formation-- that are associated with chronic infections including those observed in the cystic fibrosis (CF) lung Recently, highly effective modulator therapy (HEMT) such as elexacaftor/tezacaftor/ivacaftor (ETI) has significantly improved the quality of life of people with CF (pwCF). Yet a potential direct impact of ETI on the physiology of P. aeruginosa during growth to a remodeled CF lung environment has remained unexplored. To address this, we conducted an experimental evolution using P. aeruginosa PA14 grown in CF-like conditions in the presence or absence of ETI. We observed a marked reduction in biofilm formation and in the number of small colony variants (SCVs) for P. aeruginosa populations evolved under ETI treatment. Also, sequencing of specific evolved clones exhibiting distinct morphotypes revealed two major observations: (i) P. aeruginosa-evolved communities exposed to ETI retained a wild type-like morphotype and, (ii) P. aeruginosa populations evolved in the absence of ETI adopted a SCV-like phenotype with mutations acquired in the Wsp chemosensory pathway. Furthermore, analysis of evolved populations revealed that ETI treatment likely modulates c-di-GMP pools by driving mutations in an enzyme catalyzing the degradation of this second messenger. Overall, our work suggests that ETI has the potential to hinder the acute to chronic biofilm transition of P. aeruginosa thereby limiting the emergence of variants typically associated with long-term CF lung colonization.

Chronic Pseudomonas aeruginosa lung infections are becoming harder to treat due to global escalation of antimicrobial resistance (AMR). Bacteriophage (phage) therapy has emerged as a promising adjunct to conventional antibiotics, especially in chronic lung infections such as those seen in cystic fibrosis (CF). However, phage monotherapy may be limited by the emergence of phage-resistant bacterial populations and there remains limited preclinical evidence evaluating both antimicrobial efficacy and host safety in physiologically relevant human airway models. Here, we evaluated the safety and antimicrobial activity of Kara-mokiny 3, a myovirus bacteriophage, alone and in combination with subinhibitory concentrations of tobramycin using fully differentiated paediatric primary airway epithelial cells (pAECs) cultured at the air-liquid interface (ALI). Kara-mokiny 3 rapidly reduced P. aeruginosa viability and exhibited synergistic activity with tobramycin, resulting in significantly greater bacterial killing than either treatment alone. Importantly, phage treatment replicated efficiently in the presence of its bacterial host while preserving epithelial morphology, mucin production and epithelial barrier architecture., without inducing cytotoxicity or excessive IL-6 and IL-8 inflammatory responses. These findings demonstrate that phage-antibiotic combination therapy can enhance antimicrobial activity while maintaining epithelial safety in a physiologically relevant human airway model. This study represents one of the first comprehensive evaluations of phage-antibiotic combination therapy in differentiated primary airway epithelial cultures, providing important preclinical evidence supporting the development of personalised phage-based therapies for the treatment of MDR pulmonary infections. ImportanceThe rise of MDR P. aeruginosa has created an urgent need for alternative treatment strategies for chronic lung infections. Although phage therapy is receiving increasing clinical attention, there is limited evidence evaluating its safety and efficacy in physiologically relevant human airway models. Using differentiated primary airway epithelial cultures, we demonstrate that a phage-antibiotic combination reduces bacterial burden without compromising epithelial integrity and toxicity or excessive inflammatory responses. These findings provide translational evidence supporting phage-antibiotic combination therapy and highlight the value of primary airway epithelial models for the preclinical assessment of emerging antimicrobial interventions, supporting the translation of personalised phage therapies.

Lung transplantation (LT) is the ultimate treatment option for patients suffering from end stage cystic fibrosis (CF). Most LT-patients, colonized pre-LT by Pseudomonas aeruginosa witness colonization of their non-CF allograft within a few days or weeks post-LT, thereby compromising graft and life expectancy. How P. aeruginosa isolates adapted for years to the specific CF lung environment efficiently colonize and survive in the non-CF allograft environment remains unclear. To address this question, we collected sequential isolates from CF LT-recipients and non-CF LT-recipients and performed phenotypic and genetic analyses of pairs of early and late isolates from LT-patients. We found evidence for mutations compatible with a switch from biofilm to planktonic lifestyle as well as loss of mucoid phenotypes. Hypermutators, characteristic of chronic CF-adapted isolates, were also found in four LT-patients. Their persistence in the non-CF allograft environment suggests a continuous seeding from the sinuses. Our results suggest that in CF LT-recipients efficient colonisation by P. aeruginosa of the allograft implies both adaptation and continuous seeding from the sinuses to the lower respiratory tract.

Onion tissues produce antimicrobial thiosulfinates after tissue damage and cellular decompartmentalization. Burkholderia gladioli pv. alliicola (Bga), a common onion pathogen, encodes a thiosulfinate tolerance gene (TTG) cluster that protects the bacterium during thiosulfinate exposure. Previous work showed that the TTG cluster contributes to foliar infection but has little effect on infection of onion bulb tissue. To further examine Bga-thiosulfinate interactions in foliar and bulb tissues, we used a thiosulfinate-responsive PaltR-Lux reporter strain to determine when and where Bga encounters thiosulfinates. In leaves, Bga-induced necrosis was associated with de-repression of the PaltR-Lux reporter and coincided with a contribution of the TTG cluster to bacterial population size, indicating thiosulfinate exposure during foliar infection. In contrast, TTG mutants and wild-type (WT) strains showed similar growth in scales, and PaltR-Lux signal declined as scale necrosis progressed, suggesting limited thiosulfinate exposure during bulb colonization. However, when necrosis was induced by the non-native toxin pantaphos, PaltR-Lux was de-repressed and recovery of the TTG mutant was reduced. These results indicate that Bga encounters thiosulfinates during foliar infection but largely avoids exposure during bulb infection. Preconditioning the TTG mutant in onion scale tissue did not alter its thiosulfinate sensitivity in vitro, arguing against an infection-associated thiosulfinate exclusion mechanism. In contrast, partial rescue of the TTG mutant by the WT strain in zone-of-inhibition co-plating assays suggests extracellular thiosulfinate detoxification. Together, these findings indicate that Bga detoxifies thiosulfinates released during bulb necrosis, limiting thiosulfinate exposure during onion bulb infection. The molecular basis for detoxification and tissue specificity remain unresolved.

Antimicrobial resistance (AMR) is a major global public health threat. Wild birds, including seagulls, are increasingly recognised as potential reservoirs and disseminators of resistant bacteria linked to human activity. The objective of the study was to assess the association between human population density and the occurrence of Escherichia coli resistant to critically important antimicrobials in Australian seagulls. Faecal samples were collected from seagull populations in coastal regions across Australia representing differing human population densities. Resistant E. coli isolates were identified and characterised using multilocus sequence typing and plasmid incompatibility group analysis to determine relatedness to human associated lineages. The frequency of resistant E. coli isolation increased with human population density. The predominant sequence types ST10, ST131 and ST354 comprised 24.5% of isolates and belong to globally distributed human associated lineages linked to extraintestinal pathogenic E. coli. Many isolates carried IncF and IncI plasmids, which are key vectors of blaCTX-M extended spectrum beta lactamase genes and plasmid mediated quinolone resistance determinants commonly reported in human clinical strains. IMPORTANCEThese findings support the contention that seagulls primarily acquire resistant bacteria through contact with anthropogenic activities. Once acquired, these bacteria may be disseminated to other seagulls, birds and animals, including being transmitted to humans.

Adaptation of Escherichia coli to osmotic upshift requires rapid accumulation of intracellular solutes to restore turgor and maintain cellular homeostasis. While compatible solutes are well-established contributors to this process, they do not fully account for the early events following osmotic stress. Here, we demonstrate that inorganic phosphate and phosphorylated metabolites play a major and previously underappreciated role in osmoadaptation. Following osmotic upshift under conditions where accumulation of compatible solutes is restricted, E. coli exhibits a substantial increase in intracellular phosphate after a short lag. This increase accounts for a significant fraction of the charge balance required during rapid uptake of K+ and NH4+, the latter supporting glutamate synthesis as a principal counterion. Concomitantly, nucleotide pools display complex, multiphasic dynamics, including a transient decrease in adenylate energy charge whose duration correlates with stress magnitude. In addition, levels of pyrophosphate and key glycolytic intermediates, including dihydroxyacetone phosphate and 1,3-bisphosphoglycerate, increase markedly, indicating redistribution of phosphate into central metabolic pathways. These findings support a model in which phosphate uptake and metabolic redistribution contribute both to intracellular charge balance and to dynamic metabolic reorganisation during osmotic stress. By linking ion transport with central metabolism, this work expands current models of bacterial osmoadaptation and identifies phosphate flux as a key component of the early stress response. IMPORTANCEBacterial survival in fluctuating environments depends on rapid adaptation to osmotic stress. While compatible solutes are central to this process, their contribution does not fully account for early events in Escherichia coli following osmotic upshift. This work demonstrates that inorganic phosphate uptake and redistribution into nucleotide and glycolytic pools contribute substantially to balance the large positive charge entering the cell as it takes up K+ and NH4+ during osmotic upshift. These findings expand current models of bacterial osmoregulation by identifying phosphate flux as a central integrator of ion homeostasis and metabolic adaptation.